Okay.
Then in terms of estimating the cost, you'd be using the Quebec cost data, but we know that Canada's currently the second highest payer for pharmaceuticals in the world, or among the nations we compare to. Are you looking at any models of how a national program would be able to negotiate different prices? Are you building in thresholds around negotiations of pharmaceutical prices and providing what the projections might be?